These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1375675)

  • 1. Prolonged inhibition of local angiotensin-converting enzyme after single or repeated treatment with quinapril in spontaneously hypertensive rats.
    Nakajima T; Yamada T; Setoguchi M
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):102-7. PubMed ID: 1375675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antihypertensive activity of the angiotensin converting enzyme inhibitor quinapril HCl: (S)-2-[(S)-N-[(S)-1-ethoxycarbonyl-3-phenylpropyl) alanyl]-1,2,3,4- tetrahydro-3-isoquinolinecarboxylic acid monohydrochloride in various hypertensive animal models].
    Yaoka O; Aoki K; Nakajima T; Setoguchi M
    Nihon Yakurigaku Zasshi; 1993 Jul; 102(1):35-45. PubMed ID: 8335286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.
    Edling O; Bao G; Feelisch M; Unger T; Gohlke P
    J Pharmacol Exp Ther; 1995 Nov; 275(2):854-63. PubMed ID: 7473177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of enalapril and quinapril on forearm vascular ACE in man.
    Lyons D; Webster J; Benjamin N
    Eur J Clin Pharmacol; 1997; 51(5):373-8. PubMed ID: 9049577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and long-term effects of angiotensin converting enzyme inhibition on larger arteries and cardiac hypertrophy: mechanical and structural parameters.
    Benetos A; Albaladejo P; Levy BI; Safar ME
    J Hypertens Suppl; 1994 Jul; 12(4):S21-9. PubMed ID: 7965270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACE inhibitors and cardiac ACE mRNA in volume overload-induced cardiac hypertrophy.
    Lear W; Ruzicka M; Leenen FH
    Am J Physiol; 1997 Aug; 273(2 Pt 2):H641-6. PubMed ID: 9277479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of angiotensin-converting enzyme (ACE) in plasma and tissue.
    Fabris B; Chen BZ; Pupic V; Perich R; Johnston CI
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S6-13. PubMed ID: 1691409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and long-term dose-response study of quinapril on hormonal profile and tissue angiotensin-converting enzyme in Wistar rats.
    Schaison FH; Fernando Ramirez-Gil J; Ciferri S; Bernard M; Baudin B; Mougenot N; Carayon A; Lechat P
    J Cardiovasc Pharmacol; 1996 Jul; 28(1):11-8. PubMed ID: 8797130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats.
    Ruzicka M; Skarda V; Leenen FH
    Circulation; 1995 Dec; 92(12):3568-73. PubMed ID: 8521580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
    Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H
    Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinapril treatment and arterial smooth muscle responses in spontaneously hypertensive rats.
    Arvola P; Ruskoaho H; Wuorela H; Pekki A; Vapaatalo H; Pörsti I
    Br J Pharmacol; 1993 Apr; 108(4):980-90. PubMed ID: 8485636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin-1 upregulation in the kidney of uninephrectomized spontaneously hypertensive rats and its modification by the angiotensin-converting enzyme inhibitor quinapril.
    Largo R; Gómez-Garre D; Liu XH; Alonso J; Blanco J; Plaza JJ; Egido J
    Hypertension; 1997 May; 29(5):1178-85. PubMed ID: 9149684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
    Plosker GL; Sorkin EM
    Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of quinaprilat, an active metabolite of quinapril, on Ca2+-overload induced by lysophosphatidylcholine in isolated rat cardiomyocytes.
    Ma H; Hashizume H; Hara A; Yazawa K; Abiko Y
    Jpn J Pharmacol; 1999 Jan; 79(1):17-24. PubMed ID: 10082313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic and morphological effects of quinapril during genetic hypertension development.
    Richer C; Mulder P; Fornes P; Richard V; Camilleri JP; Giudicelli JF
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):631-42. PubMed ID: 1724542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinapril: overview of preclinical data.
    Kaplan HR; Taylor DG; Olson SC
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII6-12. PubMed ID: 2189623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of quinapril, a new angiotensin-converting enzyme inhibitor, on vasoconstrictor activity in the isolated, perfused mesenteric vasculature of hypertensive rats.
    Major TC; Overhiser RW; Taylor DG; Panek RL
    J Pharmacol Exp Ther; 1993 Apr; 265(1):187-93. PubMed ID: 8474005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats.
    Ono H; Ono Y; Frohlich ED
    Hypertension; 1996 Feb; 27(2):176-83. PubMed ID: 8567038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in L-NAME-treated rats.
    De Gennaro Colonna V; Rossoni G; Rigamonti A; Bonomo S; Manfredi B; Berti F; Muller E
    Eur J Pharmacol; 2002 Aug; 450(1):61-6. PubMed ID: 12176110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.